Expression of nitric oxide synthase, cyclooxygenase, and p53 in different stages of human gastric cancer
- 15 September 2001
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 172 (2) , 177-185
- https://doi.org/10.1016/s0304-3835(01)00645-0
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Host cyclooxygenase-2 modulates carcinoma growthJournal of Clinical Investigation, 2000
- Evidence that Expression of a Mutated p53 Gene Attenuates Apoptotic Cell Death in Human Gastric Intestinal‐type Carcinomas in vivoJapanese Journal of Cancer Research, 1997
- Expression of the Cyclooxygenase-2 Gene in Gastric EpitheliumJournal of Clinical Gastroenterology, 1997
- Expression of p53 protein as a prognostic factor in patients With gastric cancerEuropean Journal Of Cancer, 1996
- Nitric oxide synthase activity and expression in human colorectal cancerCarcinogenesis: Integrative Cancer Research, 1996
- Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumoursNature, 1996
- Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2Cell, 1995
- Inactivation of ribonucleotide reductase by nitric oxideBiochemical and Biophysical Research Communications, 1991
- Occurrence of p53 Gene Abnormalities in Gastric Carcinoma Tumors and Cells LinesJNCI Journal of the National Cancer Institute, 1991
- Estimates of the worldwide frequency of sixteen major cancers in 1980International Journal of Cancer, 1988